OpenAlex
PricingAboutJobs
Log inGet started
Work

Baseline Predictors of Systemic Lupus Erythematosus Flares: Data From the Combined Placebo Groups in the Phase III Belimumab Trials

HTML

Year: 2013
Type: article
Source: Arthritis & Rheumatism
DOI: 10.1002/art.37995
Authors: Michelle A. Petri, Ronald F. van Vollenhoven, Jill Buyon, Roger A. Levy, Sandra V. Navarra, Ricard Cervera, Z. John Zhong, William W. Freimuth, on behalf of the BLISS‐52 and BLISS‐76 Study Groups
Institutions: Johns Hopkins University, Karolinska Institutet, NYU Langone Health, Universidade do Estado do Rio de Janeiro, Hospital Universitário Pedro Ernesto, University of Santo Tomas Hospital, Hospital Clínic de Barcelona, Human Genome Sciences (United States)
Language: English

Topic: Systemic Lupus Erythematosus Research
Subfield: Rheumatology
Field: Medicine
Domain: Health Sciences
Keywords: systemic lupus erythematosus, lupus flares, belimumab, baseline disease activity, SELENA-SLEDAI, BILAG, anti-dsDNA antibodies, B lymphocyte stimulator, complement C3, proteinuria, C-reactive protein, standard treatment
SDG: Good health and well-being

Open Access status: closed

Funders: GlaxoSmithKline, Science Foundation Ireland
OpenAlex ID: W1565295739
FWCI: 9.066
Cites: 37
Cited by: 192
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms